ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646109 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646109; 2) Community: the network communities that were significantly associated with the response to NSC 646109; 3) Molecule: the relationships between components within communities and NSC 646109; 4) MDR: the compounds that were significantly associated with the NSC 646109.

NSC Compound Enrichment Correlation
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.0352786308082228 -0.10259475
NSC 641106 Benzenesulfonamide, N-[4-[[(4-carboxypheny)imino]methyl]- 3-methylphenyl]-N-(2-cyanoethyl)- 0.0352786308082228 0.020783562
NSC 114512 Null 0.0415729612483928 -0.12674758
NSC 117274 Null 0.0415729612483928 0.20409742
NSC 121713 Null 0.0415729612483928 0.022700905
NSC 140701 Sulfanilanilide, 4'-(9-acridinylamino)-, monohydrochloride 0.0415729612483928 0.15873889
NSC 189793 Streptovaricin complex, fraction a 0.0415729612483928 0.085985072
NSC 249992 M-AMSA 0.0415729612483928 0.22938159
NSC 276371 2,5-Cyclohexadiene-1,4-dione, 2,3-dimethoxy-5-[(3,7,11,15-tetramethyl-2-hexadecenyl)thio]-, [R-[R*,R*-(E)]]- 0.0415729612483928 0.10010259
NSC 295500 Camptothecin Derivative 0.0415729612483928 0.18355175
Total:47  Current:32    [First] [Prev] [Next] [Last]